-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Fujian Shengdi Pharmaceutical, a subsidiary of Hengrui, submitted a clinical application for 3 types of imitations of omega-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose (30%) injection.
In June this year, the company first declared 3 types of imitations.
Listed but not yet approved
.
Sichuan Kelun Pharmaceutical's first application for listing in 2019 has been approved for clinical use, and the domestic competition for the first imitation of this injection has become increasingly fierce
.
In June this year, the company first declared 3 types of imitations.
Listed but not yet approved
.
Sichuan Kelun Pharmaceutical's first application for listing in 2019 has been approved for clinical use, and the domestic competition for the first imitation of this injection has become increasingly fierce
.
Figure 1: The latest products declared by Fujian Shengdi Pharmaceutical
Source: CDE official website
ω-3 fish oil medium-long-chain fat emulsion/amino acid (16)/glucose (30%) injection is a three-chamber bag parenteral nutrition solution.
When oral or enteral nutrition cannot be carried out, insufficient or contraindicated, the product is medium Adult patients with moderate to severe catabolism provide the energy, essential fatty acids (including omega-3 and omega-6 fatty acids), amino acids, electrolytes and fluids required for parenteral nutrition therapy
.
When oral or enteral nutrition cannot be carried out, insufficient or contraindicated, the product is medium Adult patients with moderate to severe catabolism provide the energy, essential fatty acids (including omega-3 and omega-6 fatty acids), amino acids, electrolytes and fluids required for parenteral nutrition therapy
.
There are currently no imported or imitation products of ω-3 fish oil medium and long-chain fat emulsion/amino acids (16)/glucose (30%) on the market.
Currently, only Kelun and Hengrui have a layout
.
Currently, only Kelun and Hengrui have a layout
.
Hengrui first applied for the clinical application of omega-3 fish oil medium/long-chain fat emulsion injection in 2014 but has not yet been approved.
At present, domestic companies that have obtained the approval of omega-3 fish oil medium/long-chain fat emulsion injection include Livzon and Kelun, Kelun currently has obvious advantages in this variety, but the research and development strength of the innovative drug No.
1 cannot be underestimated.
Whether it can reverse the trend in the future is worth continuing attention
.
At present, domestic companies that have obtained the approval of omega-3 fish oil medium/long-chain fat emulsion injection include Livzon and Kelun, Kelun currently has obvious advantages in this variety, but the research and development strength of the innovative drug No.
1 cannot be underestimated.
Whether it can reverse the trend in the future is worth continuing attention
.
Table 1: Columbine's application for long-chain fat milk products in omega-3 fish oil
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Meinenet data shows that Kelun has also declared a clinical application for omega-3 fish oil medium-long-chain fat emulsion/amino acid (16)/glucose (16%) injection, which has been approved, and ω-3 fish oil medium-long-chain fat emulsion/amino acid has been approved.
(16) The marketing application for /glucose (36%) injection is under review and approval
.
(16) The marketing application for /glucose (36%) injection is under review and approval
.
Table 2: Three-chamber bag parenteral nutrition solution approved by Kelun
Source: Mi Nei.
com database, company official website
com database, company official website
According to the data, the three-chamber parenteral nutrition bag is a special soft bag that is filled with fat milk, amino acids and glucose, and separated into three relatively independent chambers.
The middle compartment can be opened during use, so that the three liquids can be fully mixed.
It better reflects the concept of "all-in-one" infusion of parenteral nutrition, and has more comprehensive advantages compared with divided bottle infusion of nutrient solution and artificially prepared nutrient solution.
It has been widely used in clinical practice and has a high market demand
.
The middle compartment can be opened during use, so that the three liquids can be fully mixed.
It better reflects the concept of "all-in-one" infusion of parenteral nutrition, and has more comprehensive advantages compared with divided bottle infusion of nutrient solution and artificially prepared nutrient solution.
It has been widely used in clinical practice and has a high market demand
.
Kelun is the leading infusion solution in China.
There are currently 4 approved products in the field of three-chamber bag parenteral nutrition, except for the ω-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose in the market application under review.
(36%) injection, as well as medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection, along with new products With successive approvals, Kelun's leading position will be more stable
.
There are currently 4 approved products in the field of three-chamber bag parenteral nutrition, except for the ω-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose in the market application under review.
(36%) injection, as well as medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection, along with new products With successive approvals, Kelun's leading position will be more stable
.
Source: CDE official website, Minet database
The review data statistics are as of November 8.
If there are any errors or omissions, please correct me
.
If there are any errors or omissions, please correct me
.
Recently, Fujian Shengdi Pharmaceutical, a subsidiary of Hengrui, submitted a clinical application for 3 types of imitations of omega-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose (30%) injection.
In June this year, the company first declared 3 types of imitations.
Listed but not yet approved
.
Sichuan Kelun Pharmaceutical's first application for listing in 2019 has been approved for clinical use, and the domestic competition for the first imitation of this injection has become increasingly fierce
.
In June this year, the company first declared 3 types of imitations.
Listed but not yet approved
.
Sichuan Kelun Pharmaceutical's first application for listing in 2019 has been approved for clinical use, and the domestic competition for the first imitation of this injection has become increasingly fierce
.
Figure 1: The latest products declared by Fujian Shengdi Pharmaceutical
Source: CDE official website
ω-3 fish oil medium-long-chain fat emulsion/amino acid (16)/glucose (30%) injection is a three-chamber bag parenteral nutrition solution.
When oral or enteral nutrition cannot be carried out, insufficient or contraindicated, the product is medium Adult patients with moderate to severe catabolism provide the energy, essential fatty acids (including omega-3 and omega-6 fatty acids), amino acids, electrolytes and fluids required for parenteral nutrition therapy
.
When oral or enteral nutrition cannot be carried out, insufficient or contraindicated, the product is medium Adult patients with moderate to severe catabolism provide the energy, essential fatty acids (including omega-3 and omega-6 fatty acids), amino acids, electrolytes and fluids required for parenteral nutrition therapy
.
There are currently no imported or imitation products of ω-3 fish oil medium and long-chain fat emulsion/amino acids (16)/glucose (30%) on the market.
Currently, only Kelun and Hengrui have a layout
.
Currently, only Kelun and Hengrui have a layout
.
Hengrui first applied for the clinical application of omega-3 fish oil medium/long-chain fat emulsion injection in 2014 but has not yet been approved.
At present, domestic companies that have obtained the approval of omega-3 fish oil medium/long-chain fat emulsion injection include Livzon and Kelun, Kelun currently has obvious advantages in this variety, but the research and development strength of the innovative drug No.
1 cannot be underestimated.
Whether it can reverse the trend in the future is worth continuing attention
.
At present, domestic companies that have obtained the approval of omega-3 fish oil medium/long-chain fat emulsion injection include Livzon and Kelun, Kelun currently has obvious advantages in this variety, but the research and development strength of the innovative drug No.
1 cannot be underestimated.
Whether it can reverse the trend in the future is worth continuing attention
.
Table 1: Columbine's application for long-chain fat milk products in omega-3 fish oil
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Meinenet data shows that Kelun has also declared a clinical application for omega-3 fish oil medium-long-chain fat emulsion/amino acid (16)/glucose (16%) injection, which has been approved, and ω-3 fish oil medium-long-chain fat emulsion/amino acid has been approved.
(16) The marketing application for /glucose (36%) injection is under review and approval
.
(16) The marketing application for /glucose (36%) injection is under review and approval
.
Table 2: Three-chamber bag parenteral nutrition solution approved by Kelun
Source: Mi Nei.
com database, company official website
com database, company official website
According to the data, the three-chamber parenteral nutrition bag is a special soft bag that is filled with fat milk, amino acids and glucose, and separated into three relatively independent chambers.
The middle compartment can be opened during use, so that the three liquids can be fully mixed.
It better reflects the concept of "all-in-one" infusion of parenteral nutrition, and has more comprehensive advantages compared with divided bottle infusion of nutrient solution and artificially prepared nutrient solution.
It has been widely used in clinical practice and has a high market demand
.
The middle compartment can be opened during use, so that the three liquids can be fully mixed.
It better reflects the concept of "all-in-one" infusion of parenteral nutrition, and has more comprehensive advantages compared with divided bottle infusion of nutrient solution and artificially prepared nutrient solution.
It has been widely used in clinical practice and has a high market demand
.
Kelun is the leading infusion solution in China.
There are currently 4 approved products in the field of three-chamber bag parenteral nutrition, except for the ω-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose in the market application under review.
(36%) injection, as well as medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection, along with new products With successive approvals, Kelun's leading position will be more stable
.
There are currently 4 approved products in the field of three-chamber bag parenteral nutrition, except for the ω-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose in the market application under review.
(36%) injection, as well as medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection, along with new products With successive approvals, Kelun's leading position will be more stable
.
Source: CDE official website, Minet database
The review data statistics are as of November 8.
If there are any errors or omissions, please correct me
.
If there are any errors or omissions, please correct me
.
Recently, Fujian Shengdi Pharmaceutical, a subsidiary of Hengrui, submitted a clinical application for 3 types of imitations of omega-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose (30%) injection.
In June this year, the company first declared 3 types of imitations.
Listed but not yet approved
.
Sichuan Kelun Pharmaceutical's first application for listing in 2019 has been approved for clinical use, and the domestic competition for the first imitation of this injection has become increasingly fierce
.
In June this year, the company first declared 3 types of imitations.
Listed but not yet approved
.
Sichuan Kelun Pharmaceutical's first application for listing in 2019 has been approved for clinical use, and the domestic competition for the first imitation of this injection has become increasingly fierce
.
Figure 1: The latest products declared by Fujian Shengdi Pharmaceutical
Source: CDE official website
ω-3 fish oil medium-long-chain fat emulsion/amino acid (16)/glucose (30%) injection is a three-chamber bag parenteral nutrition solution.
When oral or enteral nutrition cannot be carried out, insufficient or contraindicated, the product is medium Adult patients with moderate to severe catabolism provide the energy, essential fatty acids (including omega-3 and omega-6 fatty acids), amino acids, electrolytes and fluids required for parenteral nutrition therapy
.
When oral or enteral nutrition cannot be carried out, insufficient or contraindicated, the product is medium Adult patients with moderate to severe catabolism provide the energy, essential fatty acids (including omega-3 and omega-6 fatty acids), amino acids, electrolytes and fluids required for parenteral nutrition therapy
.
There are currently no imported or imitation products of ω-3 fish oil medium and long-chain fat emulsion/amino acids (16)/glucose (30%) on the market.
Currently, only Kelun and Hengrui have a layout
.
Currently, only Kelun and Hengrui have a layout
.
Hengrui first applied for the clinical application of omega-3 fish oil medium/long-chain fat emulsion injection in 2014 but has not yet been approved.
At present, domestic companies that have obtained the approval of omega-3 fish oil medium/long-chain fat emulsion injection include Livzon and Kelun, Kelun currently has obvious advantages in this variety, but the research and development strength of the innovative drug No.
1 cannot be underestimated.
Whether it can reverse the trend in the future is worth continuing attention
.
Enterprise business enterpriseAt present, domestic companies that have obtained the approval of omega-3 fish oil medium/long-chain fat emulsion injection include Livzon and Kelun, Kelun currently has obvious advantages in this variety, but the research and development strength of the innovative drug No.
1 cannot be underestimated.
Whether it can reverse the trend in the future is worth continuing attention
.
Table 1: Columbine's application for long-chain fat milk products in omega-3 fish oil
Source: Meinenet MED2.
0 Chinese Drug Evaluation Database
0 Chinese Drug Evaluation Database
Meinenet data shows that Kelun has also declared a clinical application for omega-3 fish oil medium-long-chain fat emulsion/amino acid (16)/glucose (16%) injection, which has been approved, and ω-3 fish oil medium-long-chain fat emulsion/amino acid has been approved.
(16) The marketing application for /glucose (36%) injection is under review and approval
.
(16) The marketing application for /glucose (36%) injection is under review and approval
.
Table 2: Three-chamber bag parenteral nutrition solution approved by Kelun
Source: Mi Nei.
com database, company official website
com database, company official website
According to the data, the three-chamber parenteral nutrition bag is a special soft bag that is filled with fat milk, amino acids and glucose, and separated into three relatively independent chambers.
The middle compartment can be opened during use, so that the three liquids can be fully mixed.
It better reflects the concept of "all-in-one" infusion of parenteral nutrition, and has more comprehensive advantages compared with divided bottle infusion of nutrient solution and artificially prepared nutrient solution.
It has been widely used in clinical practice and has a high market demand
.
The middle compartment can be opened during use, so that the three liquids can be fully mixed.
It better reflects the concept of "all-in-one" infusion of parenteral nutrition, and has more comprehensive advantages compared with divided bottle infusion of nutrient solution and artificially prepared nutrient solution.
It has been widely used in clinical practice and has a high market demand
.
Kelun is the leading infusion solution in China.
There are currently 4 approved products in the field of three-chamber bag parenteral nutrition, except for the ω-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose in the market application under review.
(36%) injection, as well as medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection, along with new products With successive approvals, Kelun's leading position will be more stable
.
There are currently 4 approved products in the field of three-chamber bag parenteral nutrition, except for the ω-3 fish oil medium and long-chain fat emulsion/amino acid (16)/glucose in the market application under review.
(36%) injection, as well as medium and long chain fat emulsion/amino acid (16)/glucose (30%) injection, medium and long chain fat emulsion/amino acid (16)/glucose (36%) injection, along with new products With successive approvals, Kelun's leading position will be more stable
.
Source: CDE official website, Minet database
The review data statistics are as of November 8.
If there are any errors or omissions, please correct me
.
If there are any errors or omissions, please correct me
.
